New research highlights how elevated levels of the iron-regulating hormone hepcidin contribute to psoriasis by driving skin cell proliferation and inflammation, offering fresh avenues for therapy.

However, research published in the journal Nature Communications suggests that a hormone called hepcidin could be the cause of the skin condition. Hepcidin is a hormone that helps you to regulate ...

Rusfertide, a mimetic of the natural hormone hepcidin, is currently in Phase 3 development for the rare blood disorder polycythemia vera (PV). Rusfertide is being co-developed and will be co ...

The following is a summary of “Assessment of ferritin and hepcidin levels in splenectomised and non-splenectomised ...

The Japanese pharma group is paying $300 million upfront for rights to rusfertide, an injectable hepcidin mimetic currently in the pivotal phase 3 VERIFY trial in PV that could generate ...

Hereditary hemochromatosis is an inherited iron overload disorder caused by inappropriately low hepcidin secretion leading to increased duodenal absorption of dietary iron, most commonly in C282Y ...

Protagonist Therapeutics, Inc.’s PTGX share price has surged by 6.71%, which has investors questioning if this is right time to sell.

Protagonist Therapeutics, Inc. (”Protagonist” or the “Company”) announced that an abstract was accepted for presentation at the Plenary Session at the American Society of Clinical Oncology (ASCO) ...